Recolony
Swiss start-up Recolony aims to develop an oral cancer medication using bacteria.
2-10 employees · est. 2022 · Zurich, Switzerland
VacV Biotherapeutics
Developing oncolytic viruses as therapeutics for cancer
6 employees · est. 2022 · London, United Kingdom
Side-by-Side Comparison
| Metric | Recolony | VacV Biotherapeutics |
|---|---|---|
| Founded | ||
| Founded | 2022 | 2022 |
| Headquarters | ||
| Headquarters | Zurich, Switzerland | London, United Kingdom |
| Employees | ||
| Employees | 2-10 | 6 |
| Industry | ||
| Industry | Biotechnology | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | Grant | Seed |
| Total Funding | ||
| Total Funding | $160.00K | $3.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 1 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Swiss Start-up, Recolony, Biotech, Oral Cancer, Medication, Bacteria-based, Colorectal Cancer, Microbial Solution, Therapy, Biotech Start-up, Cancer Treatment, Switzerland, Bacteria, Prevention, Treatment | Biotech, Cancer Immunotherapy, Oncolytic Virus, Viral-based Therapy, Tumor-specificity, Neurotoxicity, Therapeutic Potential, EEV Production, Biopharmaceuticals, Treatment Innovation |
| Website | ||
| Website | recolony.ch | vacvbtx.com |
About Recolony
Recolony is a Swiss biotech startup founded in 2022 with a promising goal - to develop a bacteria-based oral medication for treating and preventing cancer. Their flagship product, Recolony, offers a microbial solution specifically targeting colorectal cancer. This innovative approach holds tremendou...
About VacV Biotherapeutics
VacV Biotherapeutics, with the slogan "Developing oncolytic viruses as therapeutics for cancer," is a UK-based startup founded in 2022. The company, led by cancer immunotherapy experts Professor Yaohe Wang, Professor Nicholas Lemoine, Dr. Louisa Chard Dunmall, and Dr. Peng Liu, is focused on develop...
We will tell you when either one moves
BounceWatch watches Recolony and VacV Biotherapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Recolony and VacV Biotherapeutics — by email.
Frequently Asked Questions
Compare Recolony with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Recolony on 25 Jul 2024, and VacV Biotherapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.